| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.59 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.64 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |